Stati Uniti INTELLIA THERAPEUTICS, INC

14,36 9,45% 13:16 21/11/2024 - ISIN: US45826J1051

Raccomandazioni

Giudizio Emittente Data
+ OUTPERFORM OPPENHEIMER 11/11/2024
+ OUTPERFORM BMO CAPITAL 16/10/2024
+ BUY RBC CAPITAL 11/09/2024